# Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls

> **NCT01607125** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 96 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Vortioxetine (Lu AA21004)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01607125
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-09
- **Final completion:** —
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2013-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607125, "Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01607125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*